A new technique has enabled ultra-powerful magnetic resonance imaging (MRI) scanners to identify tiny differences in patients’ brains that cause treatment-resistant epilepsy. In the first study to use this approach, it has allowed doctors at Addenbrooke’s Hospital, Cambridge, to offer the patients surgery to cure their condition.

FRANKLIN LAKES, N.J., March 20, 2025 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the first patient treated in an Investigational Device Exemption (IDE) clinical trial intended to advance BD’s efforts to achieve Premarket Approval (PMA) from the U.S. Food and Drug Administration (FDA) for the use of GalaFLEX LITE™ Scaffold in decreasing capsular contracture (CC) recurrence during breast revision surgery.

Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination.

Cardiac Dimensions announced today that it closed an oversubscribed Series E financing round worth $53 million.

Synchron today unveiled its roadmap to Chiral, a foundation model of human cognitions for its brain-computer interface (BCI) platform.

A research team has successfully developed an innovative platform for diabetes treatment using bioink derived from pancreatic tissue and 3D bioprinting technology. This study was recently published online in Nature Communications. The team was led by Professor Jinah Jang at Pohang University of Science and Technology (POSTECH), along with Myungji Kim, a Ph.D. candidate.

Biomedical engineers at Georgia Tech have developed a system for collecting and processing thermal images that allows for reliable, detailed measurement of vital signs such as respiration and heart rate or body temperature.

The latest advance in wearable robotic technology promises to solve a 200-year-old problem by revolutionizing the fit of prosthetic limbs, transforming the lives of millions of amputees worldwide.